Stockreport

Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL [Yahoo! Finance]

Innate Pharma S.A. - American Depositary Shares  (IPHA) 
PDF of lacutamab in patients with Sézary syndrome (SS) and Mycosis fungoides (MF), who failed at least one prior line of systemic therapy. The Company submitted the confir [Read more]